IdB 1016 Treatment for Hepatitis C Disease [clinicaltrials:NCT00055445]
IdB 1016 Treatment for Hepatitis C Disease [clinicaltrials:NCT00055445]
Bio2RDF identifier
NCT00055445
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00055445
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
This study will measure ...... DICAL
CENTER IN SEATTLE
brief title [clinicaltrials_vocabulary:brief-title]
IdB 1016 Treatment for Hepatitis C Disease
completion date [clinicaltrials_vocabulary:completion-date]
2006-04-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
Results from two open l ...... 13 (follow-up after washout).
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2003-03-03T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
keyword [clinicaltrials_vocabulary:keyword]
Antioxidant
Complementary Therapies
Hepatitis C Virus
Phosphatidylcholine
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2006-08-17T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00055445
official title [clinicaltrials_vocabulary:official-title]
IdB 1016 in Hepatitis C
org study id [clinicaltrials_vocabulary:org-study-id]
R21 AT000992-01A1
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
reference [clinicaltrials_vocabulary:reference]
secondary id [clinicaltrials_vocabulary:secondary-id]
IdB-1016-UW-001
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2003-11-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2006-07-01T00:00:00Z
identifier
clinicaltrials:NCT00055445
title
IdB 1016 Treatment for Hepatitis C Disease
@en
type
label
IdB 1016 Treatment for Hepatitis C Disease [clinicaltrials:NCT00055445]
@en